This inventor holds 3 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: Celera Corporation. Active years: 2010-2021.
Company Filing History:
Years Active: 2010-2021
Title: The Innovations of Kit Lau
Introduction
Kit Lau is an accomplished inventor based in Fremont, CA (US). He has made significant contributions to the field of molecular biology, particularly in cancer research. With a total of 3 patents to his name, Lau's work focuses on developing innovative methods for predicting breast cancer metastasis.
Latest Patents
Among his latest patents is the invention titled "Molecular prognostic signature for predicting breast cancer metastasis, and uses thereof." This groundbreaking invention is based on the discovery of a unique 14-gene molecular prognostic signature that is instrumental in predicting breast cancer metastasis. The invention encompasses methods and reagents for detecting and profiling the expression levels of these genes. Furthermore, it provides methods for utilizing the expression level information to predict the risk of breast cancer metastasis.
Career Highlights
Kit Lau is currently associated with Celera Corporation, where he continues to advance his research and innovations. His work has garnered attention for its potential impact on cancer diagnostics and treatment strategies.
Collaborations
Some of his notable coworkers include Alice M Wang and Alice Wang, who have collaborated with him on various projects within the company.
Conclusion
Kit Lau's contributions to cancer research through his innovative patents highlight the importance of molecular prognostic signatures in predicting disease outcomes. His work at Celera Corporation continues to pave the way for advancements in medical science.